{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Horizons in Emergency Department Management of Pediatric Sickle Cell Disease

Activity Steps


Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify the most common organisms responsible for bloodstream infections in children with sickle cell disease.
  2. Discuss the role of opioid analgesics, nonopioid analgesics, and nonpharmacologic therapies in managing acute vaso-occlusive episodes.
  3. Describe the initial steps in the management of acute stroke in patients with sickle cell disease.
Price: FREE


  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: PEC0524
Published: May 2024
Expires: 4/30/2026
Required Passing Score: 4/5 (80%)
Authors: Jasmine Umana, MD, Ajibike Lapite, MD, MPHTM, and Angela M. Ellison, MD, MSc